SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-284564
Filing Date
2022-11-14
Accepted
2022-11-14 16:10:48
Documents
51
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d410427d8k.htm   iXBRL 8-K 28639
2 EX-99.1 d410427dex991.htm EX-99.1 113881
3 EX-99.2 d410427dex992.htm EX-99.2 37180
7 GRAPHIC g410427ex99_2p10g1.jpg GRAPHIC 370329
8 GRAPHIC g410427ex99_2p11g1.jpg GRAPHIC 439282
9 GRAPHIC g410427ex99_2p12g1.jpg GRAPHIC 455884
10 GRAPHIC g410427ex99_2p13g1.jpg GRAPHIC 325072
11 GRAPHIC g410427ex99_2p14g1.jpg GRAPHIC 102181
12 GRAPHIC g410427ex99_2p15g1.jpg GRAPHIC 442184
13 GRAPHIC g410427ex99_2p16g1.jpg GRAPHIC 460308
14 GRAPHIC g410427ex99_2p17g1.jpg GRAPHIC 274319
15 GRAPHIC g410427ex99_2p18g1.jpg GRAPHIC 224602
16 GRAPHIC g410427ex99_2p19g1.jpg GRAPHIC 302617
17 GRAPHIC g410427ex99_2p1g1.jpg GRAPHIC 101670
18 GRAPHIC g410427ex99_2p20g1.jpg GRAPHIC 315170
19 GRAPHIC g410427ex99_2p21g1.jpg GRAPHIC 272439
20 GRAPHIC g410427ex99_2p22g1.jpg GRAPHIC 181003
21 GRAPHIC g410427ex99_2p23g1.jpg GRAPHIC 88587
22 GRAPHIC g410427ex99_2p24g1.jpg GRAPHIC 250186
23 GRAPHIC g410427ex99_2p25g1.jpg GRAPHIC 210826
24 GRAPHIC g410427ex99_2p26g1.jpg GRAPHIC 346299
25 GRAPHIC g410427ex99_2p27g1.jpg GRAPHIC 240770
26 GRAPHIC g410427ex99_2p28g1.jpg GRAPHIC 324837
27 GRAPHIC g410427ex99_2p29g1.jpg GRAPHIC 298547
28 GRAPHIC g410427ex99_2p2g1.jpg GRAPHIC 567305
29 GRAPHIC g410427ex99_2p30g1.jpg GRAPHIC 86364
30 GRAPHIC g410427ex99_2p31g1.jpg GRAPHIC 300203
31 GRAPHIC g410427ex99_2p32g1.jpg GRAPHIC 269632
32 GRAPHIC g410427ex99_2p33g1.jpg GRAPHIC 244487
33 GRAPHIC g410427ex99_2p34g1.jpg GRAPHIC 257410
34 GRAPHIC g410427ex99_2p35g1.jpg GRAPHIC 70878
35 GRAPHIC g410427ex99_2p3g1.jpg GRAPHIC 390302
36 GRAPHIC g410427ex99_2p4g1.jpg GRAPHIC 290007
37 GRAPHIC g410427ex99_2p5g1.jpg GRAPHIC 294274
38 GRAPHIC g410427ex99_2p6g1.jpg GRAPHIC 95989
39 GRAPHIC g410427ex99_2p7g1.jpg GRAPHIC 331513
40 GRAPHIC g410427ex99_2p8g1.jpg GRAPHIC 267692
41 GRAPHIC g410427ex99_2p9g1.jpg GRAPHIC 444964
42 GRAPHIC g410427g05v05.jpg GRAPHIC 17880
43 GRAPHIC g410427g06v12.jpg GRAPHIC 13113
  Complete submission text file 0001193125-22-284564.txt   14064829

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA abos-20221114.xsd EX-101.SCH 2870
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abos-20221114_lab.xml EX-101.LAB 17980
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abos-20221114_pre.xml EX-101.PRE 11268
45 EXTRACTED XBRL INSTANCE DOCUMENT d410427d8k_htm.xml XML 3341
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40551 | Film No.: 221385303
SIC: 2836 Biological Products, (No Diagnostic Substances)